Man's brain tumour shrinks by half in just weeks after new treatment in UK

A man's brain tumour shrank by half within weeks after undergoing a new form of radioactive therapy in UK. Paul Read, 62, from Luton, became the first participant in a trial targeting glioblastoma brain cancer. Conducted at University College London Hospitals NHS Foundation Trust, the therapy involved injecting low levels of radioactivity directly into the tumour to eliminate cancer cells.